Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 09-Oct-24 11:25 AM View:  | Onkure Therapeutics, Inc. (OKUR) | 07-Oct-24 | Acquisition (other) | 345,739 | -- | -- | 100% 0 to 345.74K | |
| 09-Oct-24 11:25 AM View: | Onkure Therapeutics, Inc. (OKUR) | 07-Oct-24 | Acquisition (other) | 102,076 | -- | -- | 30% 345.74K to 447.81K | |
| 26-Sep-24 9:33 AM View: | Onkure Therapeutics, Inc. (OKUR) | 25-Sep-24 | Purchase | 68,746 | $1.50 | $102,872.00 | 2% 4.41M to 4.48M | |
| 26-Sep-24 9:33 AM View: | Onkure Therapeutics, Inc. (OKUR) | 24-Sep-24 | Private Purchase | 29,600 | $1.41 | $41,866.20 | < 1% 4.38M to 4.41M | |
| 19-Sep-24 11:02 AM View: | Onkure Therapeutics, Inc. (OKUR) | 18-Sep-24 | Purchase | 806 | $1.40 | $1,128.40 | < 1% 4.38M to 4.38M | |
| 19-Sep-24 11:02 AM View: | Onkure Therapeutics, Inc. (OKUR) | 17-Sep-24 | Private Purchase | 55,300 | $1.36 | $75,108.50 | 1% 4.32M to 4.38M | |
| 16-Sep-24 4:15 PM View: | Onkure Therapeutics, Inc. (OKUR) | 16-Sep-24 | Purchase | 172,747 | $1.37 | $236,871.00 | 4% 4.15M to 4.32M | |
| 16-Sep-24 4:15 PM View: | Onkure Therapeutics, Inc. (OKUR) | 13-Sep-24 | Purchase | 150,000 | $1.31 | $196,950.00 | 4% 4.0M to 4.15M | |
| 16-Sep-24 4:15 PM View: | Onkure Therapeutics, Inc. (OKUR) | 12-Sep-24 | Private Purchase | 36,176 | $1.40 | $50,523.40 | < 1% 3.96M to 4.0M | |
| 09-Sep-24 4:24 PM View: | Talis Biomedical Corp (TLIS) | 06-Sep-24 | Purchase | 25,000 | $1.48 | $37,100.00 | 11% 223.7K to 248.7K | |
| 09-Sep-24 4:24 PM View: | Talis Biomedical Corp (TLIS) | 05-Sep-24 | Private Purchase | 5,100 | $1.40 | $7,140.00 | 2% 218.6K to 223.7K | |
| 05-Sep-24 11:57 AM View: | Talis Biomedical Corp (TLIS) | 03-Sep-24 | Purchase | 500 | $4.00 | $2,000.00 | < 1% 218.1K to 218.6K | |
| 04-Sep-24 8:19 PM View: | Talis Biomedical Corp (TLIS) | 30-Aug-24 | Purchase | 151 | $4.25 | $641.75 | < 1% 218.45K to 218.6K | |
| 28-Aug-24 4:45 PM View: | Talis Biomedical Corp (TLIS) | 28-Aug-24 | Purchase | 1,215 | $3.96 | $4,814.68 | < 1% 216.74K to 217.95K | |
| 28-Aug-24 4:45 PM View: | Talis Biomedical Corp (TLIS) | 26-Aug-24 | Purchase | 13,167 | $3.90 | $51,322.30 | 6% 203.57K to 216.74K | |
| 14-Aug-24 8:24 PM View: | An2 Therapeutics, Inc. (ANTX) | 14-Aug-24 | Private Purchase | 1,500,000 | $1.04 | $1,560,000.00 | 35% 4.25M to 5.75M | |
| 14-Aug-24 8:48 PM View: | Onkure Therapeutics, Inc. (OKUR) | 14-Aug-24 | Purchase | 100,487 | $1.41 | $142,008.00 | 3% 3.86M to 3.96M | |
| 14-Aug-24 8:48 PM View: | Onkure Therapeutics, Inc. (OKUR) | 13-Aug-24 | Private Purchase | 171,339 | $1.39 | $238,590.00 | 5% 3.69M to 3.86M | |
| 05-Aug-24 3:57 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 05-Aug-24 | Purchase | 206,025 | $1.24 | $256,357.00 | < 1% 28.09M to 28.29M | |
| 05-Aug-24 3:57 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Aug-24 | Private Purchase | 167,544 | $1.29 | $216,400.00 | < 1% 27.92M to 28.09M | |
| 31-Jul-24 4:10 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 31-Jul-24 | Purchase | 100,000 | $1.33 | $132,640.00 | < 1% 27.55M to 27.65M | |
| 31-Jul-24 4:10 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 30-Jul-24 | Private Purchase | 173,730 | $1.30 | $226,370.00 | < 1% 27.38M to 27.55M | |
| 31-Jul-24 4:19 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 30-Jul-24 | Purchase | 85,800 | $7.15 | $613,470.00 | 4% 2.29M to 2.37M | |
| 22-Jul-24 4:03 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 22-Jul-24 | Purchase | 17,716 | $1.33 | $23,557.00 | < 1% 27.16M to 27.18M | |
| 22-Jul-24 4:03 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 19-Jul-24 | Purchase | 6,689 | $1.30 | $8,695.70 | < 1% 27.16M to 27.16M | |
| 22-Jul-24 4:03 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 18-Jul-24 | Private Purchase | 130,317 | $1.30 | $169,555.00 | < 1% 27.03M to 27.16M | |
| 18-Jul-24 9:16 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 18-Jul-24 | Purchase | 80,718 | $9.11 | $735,736.00 | 4% 2.21M to 2.29M | |
| 18-Jul-24 9:16 PM View: | Adverum Biotechnologies, Inc. (ADVM) | 17-Jul-24 | Purchase | 135,546 | $7.75 | $1,049,930.00 | 7% 2.07M to 2.21M | |
| 05-Jul-24 2:46 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 05-Jul-24 | Purchase | 123,017 | $1.15 | $141,334.00 | < 1% 26.51M to 26.63M | |
| 05-Jul-24 2:46 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 03-Jul-24 | Purchase | 143,288 | $1.16 | $166,071.00 | < 1% 26.36M to 26.51M | |
| 05-Jul-24 2:46 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 02-Jul-24 | Private Purchase | 86,092 | $1.14 | $98,489.20 | < 1% 26.28M to 26.36M | |
| 01-Jul-24 1:39 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 01-Jul-24 | Purchase | 107,434 | $1.14 | $122,185.00 | < 1% 24.78M to 24.88M | |
| 01-Jul-24 1:39 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 28-Jun-24 | Purchase | 1,201,000 | $1.12 | $1,348,560.00 | 5% 23.57M to 24.78M | |
| 01-Jul-24 1:39 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 27-Jun-24 | Private Purchase | 235,000 | $1.15 | $271,331.00 | 1% 23.34M to 23.57M | |
| 25-Jun-24 1:42 PM View: | Tectonic Therapeutic, Inc. (TECX) | 20-Jun-24 | Acquisition (other) | 400,355 | -- | -- | 100% 0 to 400.36K | |
| 25-Jun-24 1:42 PM View: | Tectonic Therapeutic, Inc. (TECX) | 20-Jun-24 | Acquisition (other) | 33,333 | -- | -- | 8% 400.36K to 433.69K | |
| 18-Jun-24 4:04 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 18-Jun-24 | Purchase | 50,000 | $1.13 | $56,505.00 | < 1% 22.85M to 22.9M | |
| 18-Jun-24 4:04 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 17-Jun-24 | Purchase | 150,000 | $1.13 | $169,500.00 | < 1% 22.7M to 22.85M | |
| 18-Jun-24 4:04 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 14-Jun-24 | Private Purchase | 345,000 | $1.17 | $402,201.00 | 2% 22.36M to 22.7M | |
| 13-Jun-24 6:04 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 13-Jun-24 | Purchase | 528,621 | $1.15 | $607,757.00 | 5% 10.48M to 11.01M | |
| 13-Jun-24 6:04 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 12-Jun-24 | Purchase | 82,579 | $1.14 | $94,140.10 | < 1% 10.4M to 10.48M | |
| 13-Jun-24 6:04 PM View: | Aclaris Therapeutics, Inc. (ACRS) | 11-Jun-24 | Private Purchase | 1,000,000 | $1.08 | $1,080,000.00 | 11% 9.4M to 10.4M | |
| 15-May-24 11:21 AM View: | Tectonic Therapeutic, Inc. (TECX) | 14-May-24 | Purchase | 296,882 | $1.30 | $385,947.00 | 6% 4.87M to 5.17M | |
| 16-May-24 8:58 AM View: | Onkure Therapeutics, Inc. (OKUR) | 14-May-24 | Private Purchase | 414,281 | $1.54 | $639,578.00 | 13% 3.28M to 3.69M | |
| 15-May-24 11:21 AM View: | Tectonic Therapeutic, Inc. (TECX) | 13-May-24 | Private Purchase | 469,753 | $1.25 | $585,546.00 | 11% 4.4M to 4.87M | |
| 25-Mar-24 11:05 AM View: | Cyteir Therapeutics, Inc. (CYT) | 20-Mar-24 | Private Purchase | 170,589 | $2.95 | $503,238.00 | 4% 3.82M to 3.99M | |
| 19-Mar-24 4:19 PM View: | Cyteir Therapeutics, Inc. (CYT) | 18-Mar-24 | Private Purchase | 113,777 | $3.01 | $342,469.00 | 3% 3.7M to 3.82M | |
| 04-Jan-23 7:49 PM View: | Enliven Therapeutics, Inc. (ELVN) | 04-Jan-23 | Private Sale | 1,250,000 | $4.00 | $5,000,000.00 | (38%) 3.25M to 2.0M | |
| 30-Dec-22 5:42 PM View: | Enliven Therapeutics, Inc. (ELVN) | 30-Dec-22 | Private Sale | 20,000 | $4.04 | $80,800.00 | (< 1%) 3.27M to 3.25M | |
| 29-Dec-22 5:43 PM View: | Retractable Technologies Inc. (RVP) | 29-Dec-22 | Sale | 3,000,000 | $1.60 | $4,800,000.00 | (74%) 4.08M to 1.08M |